Viatris

VTRSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$19.641 B

$17.10 +0.89%

Close of 21 Sept 2026

Revenue

$14.3B

#316 by revenue

Earnings

—

Not reported

Shares outstanding

1,148,590,864

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#22InsmedINSM$26.4B
#23United TherapeuticsUTHR$21.1B
#24ViatrisVTRS$19.6B
#25Jazz PharmaceuticalsJAZZ$15.7B
#26Ascendis Pharma A/SASND$15.6B

What if Viatris were worth as much as…

Open the what-if tool →

Gold $30.3T

$26,357.56

Per share 1,541× higher

Bitcoin $1.72T

$1,497.32

Per share 87.6× higher

Nvidia $5.48T

$4,770.94

Per share 279× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for Viatris are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.